Acalabrutinib and high-frequency low-dose subcutaneous rituximab for initial therapy of chronic lymphocytic leukemia
Autor: | Wallace, Danielle S., Zent, Clive S., Baran, Andrea M., Reagan, Patrick M., Casulo, Carla, Rice, Geoffrey, Friedberg, Jonathan W., Barr, Paul M. |
---|---|
Zdroj: | In Blood Advances 13 June 2023 7(11):2496-2503 |
Databáze: | ScienceDirect |
Externí odkaz: |